Profile data is unavailable for this security.
About the company
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD., formerly Hubei Hongcheng General Machinery Co., Ltd., is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company's products include heat-clearing and detoxifying series, digestive system series, pediatric series, breathing series, cardiovascular series and gynecology series. Its pharmaceuticals consist of tablets, mixtures, injections, capsules, granules and sprays, among others. The Company mainly distributes its products within domestic markets.
- Revenue in CNY (TTM)8.92bn
- Net income in CNY2.78bn
- Incorporated1997
- Employees5.23k
- LocationHubei Jumpcan Pharmaceutical Co LtdBaotawan, Daqing West Road, Taixing CityTAIZHOU 225441ChinaCHN
- Phone+86 52 389719161
- Fax+86 52 389719009
- Websitehttps://www.jumpcan.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nanjing King-Frind Bchmcl Phrmctcl C Ltd | 3.88bn | -422.97m | 23.15bn | 1.45k | -- | 3.69 | -- | 5.97 | -0.3269 | -0.3269 | 2.43 | 3.88 | 0.3774 | 0.5012 | 4.35 | 2,672,280.00 | -4.12 | 8.97 | -5.76 | 13.15 | 41.00 | 45.59 | -10.91 | 20.12 | 1.51 | -2.96 | 0.269 | 26.33 | 5.89 | 18.25 | -117.37 | -- | 38.32 | 13.75 |
| Shanghai Junshi Biosciences Co Ltd | 1.79bn | -1.80bn | 26.02bn | 2.53k | -- | 4.87 | -- | 14.56 | -1.83 | -1.83 | 1.81 | 6.26 | 0.1593 | 0.8406 | 4.29 | 695,986.10 | -17.55 | -18.87 | -21.98 | -23.11 | 69.07 | 69.13 | -110.18 | -88.41 | 1.75 | -67.73 | 0.3065 | -- | 3.38 | 248.39 | 4.38 | -- | 8.36 | -- |
| Zhejiang Huahai Pharmaceutical Co., Ltd. | 9.35bn | 1.14bn | 27.11bn | 8.22k | 23.78 | 3.08 | -- | 2.90 | 0.7772 | 0.7772 | 6.34 | 5.99 | 0.4922 | 1.02 | 3.51 | 1,137,186.00 | 6.01 | 5.67 | 8.37 | 8.07 | 61.97 | 60.52 | 12.21 | 11.61 | 0.7919 | 6.25 | 0.4541 | 33.55 | 0.5199 | 10.28 | -28.88 | 50.51 | 7.21 | -- |
| Hubei Jumpcan Pharmaceutical Co Ltd | 8.92bn | 2.78bn | 27.54bn | 5.23k | 9.86 | 1.96 | -- | 3.09 | 3.03 | 3.03 | 9.71 | 15.27 | 0.5135 | 3.08 | 4.60 | 1,706,101.00 | 16.04 | 16.23 | 20.68 | 20.88 | 78.36 | 82.64 | 31.23 | 24.42 | 3.55 | -- | 0.1024 | 41.76 | 7.32 | 6.02 | 30.04 | 10.83 | -14.70 | 1.11 |
| Gan & Lee Pharmaceuticals | 2.95bn | 580.86m | 28.03bn | 4.48k | 47.72 | 2.50 | -- | 9.51 | 0.9773 | 0.9773 | 4.97 | 18.65 | 0.2558 | 0.8458 | 8.94 | 657,602.00 | 5.04 | 8.30 | 5.40 | 8.83 | 72.92 | 85.39 | 19.71 | 26.44 | 6.77 | -- | 0.0005 | 13.65 | 52.31 | 1.78 | 177.37 | -18.30 | 1.50 | -- |
| Xiamen Amoytop Biotech Co Ltd | 2.60bn | 740.69m | 30.02bn | 1.96k | 40.53 | 13.26 | -- | 11.57 | 1.82 | 1.82 | 6.38 | 5.57 | 1.08 | 0.8928 | 6.18 | 1,324,099.00 | 30.73 | 17.96 | 35.90 | 21.02 | 92.71 | 90.48 | 28.54 | 19.17 | 3.60 | -- | 0.0044 | 26.95 | 37.55 | 36.19 | 93.52 | 103.28 | 81.61 | -- |
| Bluestar Adisseo Co | 14.95bn | 1.09bn | 30.25bn | 2.73k | 27.76 | 1.91 | -- | 2.02 | 0.4064 | 0.4064 | 5.57 | 5.90 | 0.6887 | 5.18 | 8.01 | 5,466,479.00 | 5.03 | 5.28 | 6.07 | 6.94 | 29.20 | 30.31 | 7.30 | 8.76 | 1.16 | 7.83 | 0.1105 | 21.81 | -9.26 | 2.92 | -95.82 | -43.75 | 2.74 | -19.09 |
Data as of Nov 22 2024. Currency figures normalised to Hubei Jumpcan Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
3.85%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2024 | 7.29m | 0.80% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 5.47m | 0.60% |
| Ping An Fund Management Co., Ltd.as of 30 Sep 2023 | 4.67m | 0.51% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 4.29m | 0.47% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 2.46m | 0.27% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 2.43m | 0.27% |
| Everbright PGIM Fund Management Co. Ltd.as of 30 Jun 2024 | 2.39m | 0.26% |
| First Seafront Fund Management Co., Ltd.as of 30 Jun 2024 | 2.38m | 0.26% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 1.98m | 0.22% |
| Taikang Asset Management Co. Ltd.as of 30 Jun 2024 | 1.88m | 0.21% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
